Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-012148
Filing Date
2022-05-12
Accepted
2022-05-12 16:31:55
Documents
50
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dyai20220331_10q.htm   iXBRL 10-Q 755679
2 EXHIBIT 31.1 ex_342531.htm EX-31.1 9527
3 EXHIBIT 31.2 ex_342532.htm EX-31.2 9399
4 EXHIBIT 32.1 ex_342533.htm EX-32.1 3801
5 EXHIBIT 32.2 ex_342534.htm EX-32.2 3789
11 dyai-20200930_g1copy.jpg GRAPHIC 8775
  Complete submission text file 0001437749-22-012148.txt   4566203

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dyai-20220331.xsd EX-101.SCH 42020
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyai-20220331_cal.xml EX-101.CAL 34437
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20220331_def.xml EX-101.DEF 298018
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20220331_lab.xml EX-101.LAB 278726
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20220331_pre.xml EX-101.PRE 312634
44 EXTRACTED XBRL INSTANCE DOCUMENT dyai20220331_10q_htm.xml XML 727545
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 22918380
SIC: 2836 Biological Products, (No Diagnostic Substances)